Health
Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies – News-Medical.Net
A thought-provoking new study server discusses the factors that determine the successful use of available vaccines to mitigate incidence and mortality rates for…
The accelerated rate of vaccine development against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in an attempt to bring an end to the coronavirus disease 2019 (COVID-19) pandemic, culminated in the approval of the Pfizer/BioNTech and Moderna vaccines under Emergency Use Authorization by the US Food and Drug Administration, as well as its European counterparts.
Both vaccines claim 95% efficacy after two doses, given three and four weeks apart for the Pfizer and Moderna vaccines,…
-
Business19 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General19 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General18 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General21 hours agoPutin says US-Ukraine text could form basis for future peace agreement